Patents by Inventor Robert Purcell

Robert Purcell has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10893181
    Abstract: An integrated color imaging system has a housing with an objective lens, photocathode and image intensifier. The image intensifier has radiation sensitive sensors and a phosphor screen. A rotatable first filter wheel is located between the objective lens and the photocathode. The first filter wheel can include first channels selectively positionable in an optical path of the image, and at least one of the first channels is clear and unfiltered. A rotatable second filter wheel can be located inside the housing between the phosphor screen and an eyepiece lens of the housing. The second filter wheel can include second channels selectively positionable in the optical path between the phosphor screen and the eyepiece lens, and at least one of the second channels is clear and unfiltered. The clear and unfiltered channels of the first and second filter wheels can be selectively aligned and held in the optical path.
    Type: Grant
    Filed: January 23, 2020
    Date of Patent: January 12, 2021
    Assignee: Chromatra, LLC
    Inventors: Peter W. J. Jones, Paul Stump, Robert Pitman, Ellen Cargill, Dennis Purcell
  • Publication number: 20200169653
    Abstract: An integrated color imaging system has a housing with an objective lens, photocathode and image intensifier. The image intensifier has radiation sensitive sensors and a phosphor screen. A rotatable first filter wheel is located between the objective lens and the photocathode. The first filter wheel can include first channels selectively positionable in an optical path of the image, and at least one of the first channels is clear and unfiltered. A rotatable second filter wheel can be located inside the housing between the phosphor screen and an eyepiece lens of the housing. The second filter wheel can include second channels selectively positionable in the optical path between the phosphor screen and the eyepiece lens, and at least one of the second channels is clear and unfiltered. The clear and unfiltered channels of the first and second filter wheels can be selectively aligned and held in the optical path.
    Type: Application
    Filed: January 23, 2020
    Publication date: May 28, 2020
    Inventors: Peter W.J. Jones, Paul Stump, Robert Pitman, Ellen Cargill, Dennis Purcell
  • Publication number: 20200122560
    Abstract: Embodiments relate to an off-road vehicle comprising a frame, including at least one cargo box support member, a suspension movably coupled to the frame, a passenger compartment, an engine, a transmission operatively coupled to the engine, and a cargo box. The cargo box includes a floor and a plurality of upwardly extending sidewalls, wherein at least a portion of the cargo box floor extends over the at least one cargo box support member and wherein the cargo box is removably coupled to the at least one cargo box support members and is removable from the off-road vehicle via the removal of fewer than eight fasteners.
    Type: Application
    Filed: December 17, 2019
    Publication date: April 23, 2020
    Inventors: Nicholas Keegan Ward, Chadwick Allen Williams, Luke Adam Baker, Ross Leonard Nygren, Aaron Lee Swanson, Cody Tove Kallock, Kyle Douglas Olason, Lucas Grant Purcell, Reid Dale Anderson, Casey Leland Root, Michael Jeffrey Lupelow, Thomas Robert Brausen, Stephen Tyler Deck, Shane Dean Kruse, Robby Gordon
  • Publication number: 20190391952
    Abstract: A method of detecting the presence of a specific medical device connected to a computer by an RS232 serial line. In one embodiment, the method includes the steps of providing an RS232 connector having a specified computer side output pin connected to specific device specified computer side input pins; raising the voltage high on the specified computer side output pin; determining which computer side input pins are voltage high; and signaling which external medical device is in communication with the computer in response to which computer side input pins are voltage high. In another embodiment, the computer side output pin is selected from one of the data terminal ready (DTR) and ready to send (RTS) pins. In yet another embodiment, the computer side input pins are selected from one or more of data set ready DSR, data carrier detect (CD) and clear to send (CTS).
    Type: Application
    Filed: July 1, 2019
    Publication date: December 26, 2019
    Applicant: Bernoulli Enterprise, Inc.
    Inventors: Joseph Purcell McGuire, Michael Lawrence Portnoy, Robert Craig Spikol, James A. Ricker
  • Publication number: 20190359393
    Abstract: A recloseable lid for closing an open top of a cup terminating in an annular upper edge includes a cup mount defining an annular channel configured to receive the annular upper edge of the cup and a cap having an annular side wall extending upwardly from the cup mount and terminating in a top having an annular floor spaced above the cup mount. A drink opening is disposed in the top and a plug assembly having a drink opening plug is provided. The drink opening plug can be selectively moveable between a closed position in which the drink opening plug is received within the drink opening for closing the drink opening and an open position in which the drink opening plug is not disposed within the drink opening. The lid can also include a plug retainer disposed in the cap and configured to retain the drink opening plug in the open position.
    Type: Application
    Filed: May 20, 2019
    Publication date: November 28, 2019
    Inventors: AARON LAYOS, CHENGTAO LI, ROBERT BRUBAKER, JACOB PURCELL, DEAN GARZA
  • Patent number: 10482530
    Abstract: A payee (300A) sends a financial document (335) such as an invoice to a payer (1A) via a payment adviser service (2001, 3001). The payer (1A) sends a financial document (45) such as an advice of payment to the payment adviser service (2001, 3001) and instructions for payment (80) to a payment clearance system (100). The payment clearance system sends to the payee (300A) information on where to access the financial document (45) by including it in the payee's bank statement (315).
    Type: Grant
    Filed: February 19, 2019
    Date of Patent: November 19, 2019
    Assignee: JAGWOOD PTY LTD
    Inventors: Andrew Blair, James Robert Hancock, Geoffrey Charles Purcell, Robin James Beauchamp
  • Publication number: 20190321457
    Abstract: The present invention provides methods for enhancing the efficacy and/or safety of a vaccine. In certain embodiments, the invention provides methods to increase or potentiate the immune response to a vaccine in a subject in need thereof. The methods of the present invention comprise administering to a subject in need thereof an interleukin-4 receptor (IL-4R) antagonist such as an anti-IL-4R antibody in combination with said vaccine. In certain embodiments, the methods of the present invention are used to afford enhanced protection to an infectious disease such as whooping cough.
    Type: Application
    Filed: April 29, 2019
    Publication date: October 24, 2019
    Inventors: Lisa Purcell, Neil Graham, Andrew J. Murphy, Robert Evans
  • Publication number: 20190213672
    Abstract: A payee (300A) sends a financial document (335) such as an invoice to a payer (1A) via a payment adviser service (2001, 3001). The payer (1A) sends a financial document (45) such as an advice of payment to the payment adviser service (2001, 3001) and instructions for payment (80) to a payment clearance system (100). The payment clearance system sends to the payee (300A) information on where to access the financial document (45) by including it in the payee's bank statement (315).
    Type: Application
    Filed: February 19, 2019
    Publication date: July 11, 2019
    Applicant: Jagwood Pty Ltd.
    Inventors: Andrew Blair, James Robert Hancock, Geoffrey Charles Purcell, Robin James Beauchamp
  • Patent number: 10314904
    Abstract: The present invention provides methods for enhancing the efficacy and/or safety of a vaccine. In certain embodiments, the invention provides methods to increase or potentiate the immune response to a vaccine in a subject in need thereof. The methods of the present invention comprise administering to a subject in need thereof an interleukin-4 receptor (IL-4R) antagonist such as an anti-IL-4R antibody in combination with said vaccine. In certain embodiments, the methods of the present invention are used to afford enhanced protection to an infectious disease such as whooping cough.
    Type: Grant
    Filed: February 17, 2017
    Date of Patent: June 11, 2019
    Assignee: Regeneron Pharmaceuticals, Inc.
    Inventors: Lisa Purcell, Neil Graham, Andrew J. Murphy, Robert Evans
  • Patent number: 10314422
    Abstract: An apparatus for dispensing a disposable polymeric film and applying it to the hand of a user or an object, in which a stream of air drawn into an enclosed inflation chamber through a constricted opening aligned with an open end of the polymeric film inflates the topmost of a stack of polymeric films in the chamber so that a user can readily insert his hand or an object into the polymeric film. After the user has donned the polymeric film on the hand or an object has been placed in the polymeric film, a wall of the chamber is opened to permit the user to readily withdraw his hand or the object from the chamber while the air flow which originally inflated the top-most polymeric film is disrupted. Upon closure of the chamber wall, the re-established air flow automatically inflates the next lower polymeric film in the polymeric film stack to prepare the next polymeric film for receipt of another hand or object.
    Type: Grant
    Filed: February 21, 2017
    Date of Patent: June 11, 2019
    Inventors: David Scott Purcell, John Robert Morris
  • Patent number: 10100346
    Abstract: The present invention relates to molecular approaches to the production of nucleic acid sequences, which comprises the genome of infectious hepatitis C virus. In particular, the invention provides nucleic acid sequences which comprise the genomes of infectious hepatitis C viruses of either genotype 3a (strain S52) or genotype 4a (strain ED43). The invention therefore relates to the use of the nucleic acid sequences and polypeptides encoded by all or part of the sequences in the development of vaccines and diagnostic assays for HCV and in the development of screening assays for the identification of antiviral agents for HCV. The invention therefore also relates to the use of viral particles derived from laboratory animals infected with S52 and ED43 viruses.
    Type: Grant
    Filed: April 28, 2017
    Date of Patent: October 16, 2018
    Assignees: Hvidovre Hospital, The United States of America, as Represented by the Secretary, Department of Health and Human Services
    Inventors: Judith M. Gottwein, Troels Kasper Hoyer Scheel, Robert Purcell, Jens Bukh
  • Publication number: 20170240950
    Abstract: The present invention relates to molecular approaches to the production of nucleic acid sequences, which comprises the genome of infectious hepatitis C virus. In particular, the invention provides nucleic acid sequences which comprise the genomes of infectious hepatitis C viruses of either genotype 3a (strain S52) or genotype 4a (strain ED43). The invention therefore relates to the use of the nucleic acid sequences and polypeptides encoded by all or part of the sequences in the development of vaccines and diagnostic assays for HCV and in the development of screening assays for the identification of antiviral agents for HCV. The invention therefore also relates to the use of viral particles derived from laboratory animals infected with S52 and ED43 viruses.
    Type: Application
    Filed: April 28, 2017
    Publication date: August 24, 2017
    Inventors: Judith M. Gottwein, Troels Kasper Hoyer Scheel, Robert Purcell, Jens Bukh
  • Patent number: 9683269
    Abstract: The present invention relates to molecular approaches to the production of nucleic acid sequences, which comprises the genome of infectious hepatitis C virus. In particular, the invention provides nucleic acid sequences which comprise the genomes of infectious hepatitis C viruses of either genotype 3a (strain S52) or genotype 4a (strain ED43). The invention therefore relates to the use of the nucleic acid sequences and polypeptides encoded by all or part of the sequences in the development of vaccines and diagnostic assays for HCV and in the development of screening assays for the identification of antiviral agents for HCV. The invention therefore also relates to the use of viral particles derived from laboratory animals infected with S52 and ED43 viruses.
    Type: Grant
    Filed: October 14, 2014
    Date of Patent: June 20, 2017
    Assignees: Hvidovre Hospital, The United States of America, As Represented by the Secretary, Department of Health and Human Services
    Inventors: Judith M. Gottwein, Troels Kasper Hoyer Scheel, Robert Purcell, Jens Bukh
  • Publication number: 20150105290
    Abstract: The present invention relates to molecular approaches to the production of nucleic acid sequences, which comprises the genome of infectious hepatitis C virus. In particular, the invention provides nucleic acid sequences which comprise the genomes of infectious hepatitis C viruses of either genotype 3a (strain S52) or genotype 4a (strain ED43). The invention therefore relates to the use of the nucleic acid sequences and polypeptides encoded by all or part of the sequences in the development of vaccines and diagnostic assays for HCV and in the development of screening assays for the identification of antiviral agents for HCV. The invention therefore also relates to the use of viral particles derived from laboratory animals infected with S52 and ED43 viruses.
    Type: Application
    Filed: October 14, 2014
    Publication date: April 16, 2015
    Inventors: Judith M. Gottwein, Troels Kasper Hoyer Scheel, Robert Purcell, Jens Bukh
  • Patent number: 8946398
    Abstract: The present invention relates to molecular approaches to the production of nucleic acid sequences, which comprises the genome of infectious hepatitis C virus. In particular, invention provides nucleic acid sequences which comprise the genomes of infectious hepatitis C viruses of either genotype 3a (strain S52) or genotype 4a (strain ED43). The invention therefore relates to the use of the nucleic acid sequences and polypeptides encoded by all or part of the sequences in the development of vaccines and diagnostic assays for HCV and in the development of screening assays for the identification of antiviral agents for HCV. The invention therefore also relates to the use of viral particles derived from laboratory animals infected with S52 and ED43 viruses.
    Type: Grant
    Filed: September 16, 2010
    Date of Patent: February 3, 2015
    Assignees: Hvidovre Hospital, The United States of America, as represented by the Secretary, Department of Health and Human Services
    Inventors: Judith M. Gottwein, Troels Kasper Hoyer Scheel, Robert Purcell, Jens Bukh
  • Publication number: 20120189648
    Abstract: The present invention relates to molecular approaches to the production of nucleic acid sequences, which comprises the genome of infectious hepatitis C virus. In particular, invention provides nucleic acid sequences which comprise the genomes of infectious hepatitis C viruses of either genotype 3a (strain S52) or genotype 4a (strain ED43). The invention therefore relates to the use of the nucleic acid sequences and polypeptides encoded by all or part of the sequences in the development of vaccines and diagnostic assays for HCV and in the development of screening assays for the identification of antiviral agents for HCV. The invention therefore also relates to the use of viral particles derived from laboratory animals infected with S52 and ED43 viruses.
    Type: Application
    Filed: September 16, 2010
    Publication date: July 26, 2012
    Applicant: HVIDOVRE HOSPITAL
    Inventors: Judith M. Gottwein, Troels Kasper Hoyer Scheel, Robert Purcell, Jens Bukh
  • Patent number: 7635476
    Abstract: Chimpanzee monoclonal antibodies and antigen binding fragments including a ?1-chain CDR3 region that bind hepatitis A virus (HAV) antigen are disclosed herein. The antibodies neutralize HAV. Also disclosed are methods for using these antibodies and antigen binding fragments in the detection of hepatitis A virus, the inhibition of infection of a subject with hepatitis A virus, and in screening for agents that affect HAV.
    Type: Grant
    Filed: April 23, 2007
    Date of Patent: December 22, 2009
    Assignee: The United States of America as represented by the Secretary of the Department of Health and Human Services
    Inventors: Darren J. Schofield, Suzanne U. Emerson, Robert Purcell, II
  • Publication number: 20090311248
    Abstract: The invention relates to anti-HCV antibodies and more specifically to neutralizing anti-HCV antibodies and their variable and complementarity determining regions (CDR). In particular, the neutralizing anti-HCV antibodies are neutralizing anti-HCV envelope protein 1 (HCV E1) antibodies. Also subject of the invention are compositions comprising these antibodies, CDRs or variable regions, and compounds comprising at least one of the CDRs or variable regions of said antibodies. Further subject of the invention are the application of any of said antibodies, CDRs, variable regions or compounds in HCV prophylaxis, therapy, and diagnosis, as well as methods for producing the antibodies.
    Type: Application
    Filed: March 22, 2007
    Publication date: December 17, 2009
    Inventors: Erik Depla, Robert Purcell, Jens Bukh, Suzanne Emerson, Jean-Christophe Meunier
  • Publication number: 20090104207
    Abstract: The invention relates to anti-HCV antibodies and more specifically to neutralizing anti-HCV antibodies and their variable and complementarity determining regions (CDR). In particular, the neutralizing anti-HCV antibodies are neutralizing anti-HCV envelope protein 1 (HCV E1) antibodies. Also subject of the invention are compositions comprising these antibodies, CDRs or variable regions, and compounds comprising at least one of the CDRs or variable regions of said antibodies. Further subject of the invention are the application of any of said antibodies, CDRs, variable regions or compounds in HCV prophylaxis, therapy, and diagnosis, as well as methods for producing the antibodies.
    Type: Application
    Filed: March 22, 2007
    Publication date: April 23, 2009
    Inventors: Erik Depla, Robert Purcell, Jens Bukh, Suzanne Emerson, Jens-Christophe Meunier
  • Publication number: 20080014212
    Abstract: The present invention discloses nucleic acid sequences which encode infectious hepatitis C viruses and the use of these sequences, and polypeptides encoded by all or part of these sequences, in the development of vaccines and diagnostics for HCV and in the development of screening assays for the identification of antiviral agents for HCV.
    Type: Application
    Filed: April 9, 2007
    Publication date: January 17, 2008
    Inventors: Masayuki Yanagi, Jens Bukh, Suzanne Emerson, Robert Purcell